• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Immune Marker and Viral DNA Predict Diffuse Large B-Cell Lymphoma Survival

by
November 10, 2026
in Health
Reading Time: 3 mins read
0
Immune Marker and Viral DNA Predict Diffuse Large B-Cell Lymphoma Survival

Immune Marker and Viral DNA Predict Diffuse Large B-Cell Lymphoma Survival

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An integrated prognostic model combining the systemic lymphocyte-to-monocyte ratio and circulating Epstein–Barr virus DNA status provides valuable complementary prognostic information beyond standard clinical risk scoring in patients diagnosed with diffuse large B-cell lymphoma, according to a retrospective study conducted by clinical researchers at the Second Hospital of Anhui Medical University and Tongling People’s Hospital in China. Reporting in the journal Frontiers in Cellular and Infection Microbiology, the research team developed and internally validated the novel framework to improve individual risk stratification, establishing that combining host inflammatory markers with circulating viral indicators provides measurable incremental value over existing prognostic systems.

In contemporary oncology practice, the International Prognostic Index remains the primary cornerstone for risk stratification and clinical decision-making. However, the study investigators noted that this established prognostic index primarily reflects conventional clinical variables and does not fully capture underlying host immune-inflammatory conditions or virus-associated biological features that may critically influence disease progression and patient survival.

To address these recognized prognostic deficiencies, the investigators designed their study to identify the optimal systemic inflammatory biomarker from routinely measured blood parameters and combine it with viral status into an accessible clinical framework. The retrospective study analyzed a clinical cohort of 485 newly diagnosed patients with diffuse large B-cell lymphoma. Within this cohort, the authors conducted a direct comparative assessment among four widely investigated systemic inflammatory biomarkers: the neutrophil-to-lymphocyte ratio, the platelet-to-lymphocyte ratio, the lymphocyte-to-monocyte ratio, and the systemic immune-inflammation index.

Comparative statistical evaluation revealed that among the four candidate inflammatory indicators, the lymphocyte-to-monocyte ratio demonstrated the superior prognostic discrimination for overall survival, clearly outperforming the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index. To determine the most accurate prognostic cutoff value for this biomarker, the investigators employed maximally selected rank statistics.

Using Kaplan–Meier survival curve analysis and multivariable Cox proportional hazards regression models, the researchers evaluated the independent prognostic associations of the biomarkers. Furthermore, within the cohort of patients evaluable for viral presence, pretreatment circulating Epstein–Barr virus DNA positivity was independently associated with adverse overall survival as well as shortened progression-free survival.

Drawing upon these dual findings, the investigators developed a combined lymphocyte-to-monocyte ratio and circulating Epstein–Barr virus DNA risk score. This integrated scoring system effectively stratified the evaluated patients into three distinct prognostic tiers, classifying individuals into low-risk, intermediate-risk, and high-risk groups. When tracking patient trajectories across these stratified risk categories, the researchers observed statistically significant differences in both overall survival and progression-free survival outcomes, demonstrating the complementary prognostic utility achieved by evaluating systemic inflammation alongside viral status.

To create an individualized prognostic tool suitable for clinical translation, the authors subsequently incorporated the combined risk score with the conventional International Prognostic Index to construct a comprehensive predictive nomogram. The researchers subjected the integrated nomogram to internal validation using bootstrap resampling methods. The resulting integrated model demonstrated superior prognostic discrimination, enhanced calibration accuracy, improved clinical utility, and more effective risk reclassification compared with assessments relying exclusively on the conventional International Prognostic Index alone.

In their concluding evaluation, the study authors offered important qualifications regarding the clinical translation of their findings. Although the integrated model successfully provided complementary prognostic information and demonstrated modest incremental value beyond the conventional International Prognostic Index, the model displayed moderate overall discrimination and calibration within the retrospective cohort.

The research effort, published in the Virus and Host section of Frontiers in Cellular and Infection Microbiology, was conducted by Li Yan, Xiaoyu Wang, Ya Liao, Jiajia Wang, Xinlu Jiang, Fan Wu, and corresponding author Zhimin Zhai.

Subject of Research: Prognostic model combining lymphocyte-to-monocyte ratio and circulating EBV-DNA in diffuse large B-cell lymphoma

Article Title: Development and internal validation of an integrated prognostic model incorporating lymphocyte-to-monocyte ratio and circulating EBV-DNA in diffuse large B-cell lymphoma

Article References: Yan, L., Wang, X., Liao, Y., Jiang, X., Wu, F., Wang, J., & Zhai, Z. (2026). Development and internal validation of an integrated prognostic model incorporating lymphocyte-to-monocyte ratio and circulating EBV-DNA in diffuse large B-cell lymphoma. Frontiers in Cellular and Infection Microbiology, 16, Article 1980261. https://doi.org/10.3389/fcimb.2026.1980261

Image Credits: AI Generated

DOI: 10.3389/fcimb.2026.1980261

Keywords: diffuse large B-cell lymphoma, lymphocyte-to-monocyte ratio, Epstein-Barr virus, circulating EBV-DNA, International Prognostic Index, prognostic model, risk stratification, biomarkers, Development, internal, validation, integrated

News Source: Nathaniel Bowman. (November 10, 2026). Immune Marker and Viral DNA Predict Diffuse Large B-Cell Lymphoma Survival. Scienmag.

Tags: biomarkerscirculating EBV-DNADevelopmentdiffuse large B-cell lymphomaEpstein-Barr virusintegratedinternalInternational Prognostic Indexlymphocyte-to-monocyte ratioprognostic modelrisk stratificationValidation
Share12Tweet7Share2ShareShareShare1

Related Posts

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

November 17, 2026
Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer's and Parkinson's

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

November 17, 2026

Posterior Cruciate Ligament Continuously Lengthens Across Knee Flexion in Healthy Adults

November 17, 2026

3D-Printed Guide Template Associated With Improved Spinal Deformity Correction in Cohort

November 17, 2026

POPULAR NEWS

  • Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    29 shares
    Share 12 Tweet 7
  • Gut Microbiota and Metabolites Influence Immunotherapy Response in Liver Cancer

    29 shares
    Share 12 Tweet 7
  • Nonlinear Sex-Specific Remodeling of the TCRβ Repertoire During Adult Aging

    29 shares
    Share 12 Tweet 7
  • Capped Nanovials Enable Extended Cell Growth and Screening in UCLA Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.